EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 299 filers reported holding EXELIXIS INC in Q1 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,236,000 | -7.3% | 58,469 | -20.1% | 0.35% | -6.6% |
Q2 2021 | $1,334,000 | -28.6% | 73,215 | -11.5% | 0.38% | -36.9% |
Q1 2021 | $1,869,000 | +8.9% | 82,730 | -3.3% | 0.60% | +10.1% |
Q4 2020 | $1,717,000 | -19.8% | 85,545 | -2.3% | 0.55% | -28.8% |
Q3 2020 | $2,142,000 | +0.0% | 87,590 | -2.9% | 0.77% | -9.3% |
Q2 2020 | $2,141,000 | +41.7% | 90,170 | +2.7% | 0.85% | +5.1% |
Q1 2020 | $1,511,000 | -2.1% | 87,760 | +0.2% | 0.80% | +15.7% |
Q4 2019 | $1,543,000 | -6.9% | 87,560 | -6.6% | 0.70% | -16.0% |
Q3 2019 | $1,658,000 | -16.8% | 93,765 | -2.1% | 0.83% | -12.3% |
Q2 2019 | $1,993,000 | -15.7% | 95,810 | -3.5% | 0.94% | -18.4% |
Q1 2019 | $2,364,000 | +26.6% | 99,325 | +4.6% | 1.16% | +7.4% |
Q4 2018 | $1,868,000 | -10.1% | 94,945 | -19.1% | 1.08% | +14.1% |
Q3 2018 | $2,078,000 | -17.5% | 117,290 | +0.1% | 0.94% | -28.5% |
Q2 2018 | $2,520,000 | +24.8% | 117,120 | +28.5% | 1.32% | +17.9% |
Q1 2018 | $2,019,000 | – | 91,165 | – | 1.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 17,416,738 | $422,007,000 | 64.06% |
Matrix Capital Management Company, LP | 15,117,460 | $366,296,000 | 11.71% |
Rhenman & Partners Asset Management AB | 1,050,000 | $25,442,000 | 3.25% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 254,334 | $6,163,000 | 2.40% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 790,148 | $19,145,000 | 1.30% |
Jupiter Investment Management Ltd | 4,182,760 | $101,348,000 | 1.06% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 50,818 | $1,231,000 | 0.70% |
C M BIDWELL & ASSOCIATES LTD | 17,475 | $423,000 | 0.65% |
QCM Cayman, Ltd. | 9,562 | $232,000 | 0.60% |
Handelsinvest Investeringsforvaltning | 98,500 | $2,387,000 | 0.56% |